Pfizer-BioNTech vaccine decreases chances of hospitalisation from Covid-19 across all variants; finds study
New Covid study to establish effectiveness of vaccine Pfizer-BioNTech vaccine is effective in reducing hospitalisation for Covid-19 cases across all variants, says a new study by Kaiser Permanente and Pfizer. The study published in The Lancet has found that the vaccine is effective up to 90 per cent across all variants for six months for … Read more